StockData
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. (PCRX) stock

PCRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3028% above fair value
$36.48+0.00 (0.00%)

Close on Nov 17, 2026Market cap $1.45BP/E 104.2Yield –

Pacira BioSciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Pacira BioSciences's price to book ratio was 2.2× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.8× to 4.7×, with a median of 1.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.2×+0.6
2025Dec 31, 20251.5×+0.4
2024Dec 31, 20241.2×−0.7
2023Dec 29, 20231.9×−0.4
2022Dec 30, 20222.3×−1.4
2021Dec 31, 20213.7×−0.7
2020Dec 31, 20204.4×−1.0
2019Dec 31, 20195.5×−0.4
2018Dec 31, 20185.9×−1.1
2017Dec 29, 20177.0×+1.4
2016Dec 30, 20165.6×−7.9
2015Dec 31, 201513.5×−7.1
2014Dec 31, 201420.6×−18.6
2013Dec 31, 201339.2×+32.2
2012Dec 31, 20127.1×−3.7
2011Dec 30, 201110.7×–

More Pacira BioSciences figures

See a number that looks wrong?